The pathophysiology of estrogen in perinatal depression: conceptual update
- PMID: 39096394
- DOI: 10.1007/s00737-024-01494-6
The pathophysiology of estrogen in perinatal depression: conceptual update
Abstract
Purpose: Estrogen levels fall sharply after parturition and have long been considered an etiologic contributor to postpartum depression (PPD); however, no differences have been reported in plasma hormone concentrations in people who develop PPD. We examine the question: What is the current view of estrogen and the neurophysiologic processes it impacts in the development and treatment of PPD?
Methods: A literature review of the role of estrogen on candidate hormonal and epigenetic systems in the peripartum period was performed, including landmark historical studies and recent publications on estrogen-related research. The authors reviewed these papers and participated in reaching consensus on a conceptual framework of estrogen activity within the complexity of pregnancy physiology to examine its potential role for driving novel interventions.
Results: Estrogen fluctuations must be conceptualized in the context of multiple dramatic and interacting changes inherent in pregnancy and after birth, including progesterone, corticosteroids, inflammation, circadian biology and psychosocial challenges. Individuals who develop PPD have increased sensitivity to epigenetic alteration at estrogen-responsive genes, and these changes are highly predictive of PPD. An effective estrogen-based treatment for PPD has yet to be found, but interventions focused on associated inflammation and circadian rhythms are promising.
Conclusions: Our understanding of the biological basis of PPD, one of the most common morbidities of the perinatal period, is expanding beyond changes in gynecologic hormone concentrations to include their impact on other systems. This growing understanding of the many processes influencing PPD will allow for the development of novel prevention and treatment strategies.
Keywords: Estrogen; Postpartum depression.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. The authors have no acknowledgements or disclosures
References
-
- Achtyes E, Keaton SA, Smart L, Burmeister AR, Heilman PL, Krzyzanowski S, Brundin L (2020) Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression. Brain Behav Immun 83:239–247. https://doi.org/10.1016/j.bbi.2019.10.017 - DOI - PubMed
-
- Administration US, Food, Drug (2023) FDA Approves First Oral Treatment for Postpartum Depression. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-o...
-
- Ahokas A, Kaukoranta J, Wahlbeck K, Aito M (2001) Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 62(5):332–336. https://doi.org/10.4088/jcp.v62n0504 - DOI - PubMed
-
- Alvord VM, Kantra EJ, Pendergast JS (2022) Estrogens and the circadian system. Semin Cell Dev Biol 126:56–65. https://doi.org/10.1016/j.semcdb.2021.04.010 - DOI - PubMed
-
- Association, American Psychiatric (2022). Depressive Disorders. In Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev. ed.)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
